NCT02167542

Brief Summary

It has been demonstrated the application of noninvasive positive pressure ventilation (NPPV) to assist spontaneous breathing through a face mask during fiberoptic bronchoscopy (FOB) with bronchoalveolar lavage (BAL) in severely hypoxemic, nonintubated patients. With NPPV, FOB was well-tolerated, significantly improved the PaO2/FiO2 ratio, and successfully avoided the need for endotracheal intubation. Two randomized studies have provided supporting evidence that the application of NPPV or CPAP via a face mask was superior to oxygen supplementation alone during FOB. For this reason patients who require FOB and are hypoxemic and/or mild hypercapnic (TcCO2 \< 60mmHg) will be compared in a randomized study by comparing NPPV vs CPAP Boussignac (Vygon) delivered through a face mask.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2010

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2010

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

September 15, 2011

Completed
2.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2014

Completed
5 months until next milestone

First Posted

Study publicly available on registry

June 19, 2014

Completed
Last Updated

June 19, 2014

Status Verified

June 1, 2014

Enrollment Period

7 months

First QC Date

September 15, 2011

Last Update Submit

June 18, 2014

Conditions

Keywords

Severe hypoxemic respiratory failureFiberoptic bronchoscopyNoninvasive possitive pressure ventilationContinuous positive airway pressure

Outcome Measures

Primary Outcomes (1)

  • Change in arterial parcial oxygen pressure / Inspired oxygen fraction ratio (PaO2/FiO2)

    Before and 5 min after the exam (FOB)

Secondary Outcomes (4)

  • Electrocardiogram

    up to 60 min after FOB

  • Heart Rate

    up to 60 min after FOB

  • Respiratory Rate

    up to 60 min after FOB

  • Peripheal oxygen saturation

    up to 60 min after FOB

Study Arms (2)

NPPV group

EXPERIMENTAL

Patients assigned to noninvasive positive pressure ventilation (NPPV) are connected to the ventilator through a face mask (VBM Endoscopy Mask) that is secured to the patient's face by the investigator.

Device: Noninvasive Positive Pressure Ventilation

CPAP valve group

ACTIVE COMPARATOR

Patients assigned to CPAP valve (Boussignac valve, Vygon, Inc) are connected to this device through a standard face mask that is secured to the patient's face with elastic straps.

Device: CPAP valve (Boussignac)

Interventions

Patients assigned to NPPV were connected to the ventilator through a face mask (VBM Endoscopy Mask) that was secured to the patient's face by the investigator. Only one type of mechanical ventilator will be used (Vision, Philips Respironics). Ventilator parameters and supplemental oxygen will be titrated by the investigator to achieve SpO2\>92%. Ventilatory support via face mask will be maintained with the same pressures for at least 30min after FOB, and then will be replaced by the FIO2 mask's if needed.

NPPV group

Patients assigned to CPAP Boussignac valve are connected to this device through a face mask that is secured to the patient's face with elastic straps. This kind of CPAP allows the delivery of pressure by constant-flow oxygen insufflation. Four funnel-shaped microchannels are included in the wall of this device and connected to an external opening connected to the oxygen source. These microchannels generate high-velocity microjets, which in turn generate the pressure resulting from the air entrainment mechanism thus created. Oxygen flow will be titrated by the investigator to ensure SpO2\>92%.

CPAP valve group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • need for FOB;
  • hypoxemia, defined by pulse oximetry (SpO2) \>92% under oxygen supplementation;
  • mild hypercapnia, defined by transcutaneous CO2 (PaCO2) \<60mmHg;
  • already under domiciliary NPPV.

You may not qualify if:

  • emergent intubation;
  • recent (less than 1 wk) acute myocardial infarction;
  • ph bellow 7.30;
  • PaCo2 \> 60mmHg;
  • systolic blood pressure \< 80mmHg;
  • encephalopathy or coma.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Broncology Unit, Pulmonology Department, University Hospital São João

Porto, Porto District, 4200-319, Portugal

Location

Related Publications (1)

  • Antonelli M, Conti G, Rocco M, Arcangeli A, Cavaliere F, Proietti R, Meduri GU. Noninvasive positive-pressure ventilation vs. conventional oxygen supplementation in hypoxemic patients undergoing diagnostic bronchoscopy. Chest. 2002 Apr;121(4):1149-54. doi: 10.1378/chest.121.4.1149.

    PMID: 11948045BACKGROUND

MeSH Terms

Conditions

Respiratory Insufficiency

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract Diseases

Study Officials

  • Miguel R Gonçalves, Ph.D

    Lung Function and Ventilation Unit, Pulmonology Department, University Hospital São João

    PRINCIPAL INVESTIGATOR
  • Tiago F Pinto, MSc

    Lung Function and Ventilation Unit, Pulmonology Department, University Hospital São João

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

September 15, 2011

First Posted

June 19, 2014

Study Start

February 1, 2010

Primary Completion

September 1, 2010

Study Completion

February 1, 2014

Last Updated

June 19, 2014

Record last verified: 2014-06

Locations